<DOC>
	<DOCNO>NCT00761371</DOCNO>
	<brief_summary>Imiquimod 5 % cream treatment external genital perianal wart HIV+ patient</brief_summary>
	<brief_title>Imiquimod 5 % Cream Treatment External Genital Perianal Warts HIV+ Patients</brief_title>
	<detailed_description>To evaluate percentage HIV+ subject successfully treat HAART , total clearance ( 100 % ) baseline external genital perianal wart within 16 week treatment imiquimod 5 % cream .</detailed_description>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>1 . Subject able understand willing give write informed consent . 2 . Subject ≥ 18 &lt; 70 year age . 3 . Male female HIV infection document serology ( enzyme link immunoabsorbent assay ( ELISA ) ) , Western Blot assay , HIV viral load . 4 . Treated HAART least six month compliant treatment . 5 . Evidence efficacy HAART : total CD4+ lymphocyte count ≥ 200 cells/mm3 AND plasma HIV RNA level &lt; 104 RNA copies/mL within four week prior Treatment Initiation Visit . 6 . Presence least one visible genital perianal wart determine clinical diagnosis . 7 . Total wart area &gt; 10 mm2 ≤ 4000 mm2 ( diameter &gt; 0.4 cm ≤ 7.1 cm ) 8 . Karnofsky Performance Status ≥ 70 % . 9 . Accepting abstain sexual intercourse study drug skin . 10 . In case coexist AIDSdefining illness , illness treatment receive must stable four week precede enrolment trial . 11 . If female childbearing potential , negative urine pregnancy test , willing use medically acceptable method contraception 16week treatment period . Subjects consider childbearing potential unless uterus ovary remove two year postmenopausal . For study , follow consider acceptable method contraception : Surgical sterilization , define tubal ligation subject vasectomy subject 's partner subject monogamous heterosexual relationship ( Investigator 's discretion ) Oral , injectable , implantable contraceptive Condoms ( spermicide ) Diaphragm/cervical cap ( spermicide ) Intrauterine device ( IUDs ) Complete abstinence ( Investigator 's discretion ) 1 . Women pregnant lactating ; 2 . Treatment within four week prior Treatment Initiation Visit throughout entire study : Any genital wart therapy , Immunomodulators Systemic antiviral drug acyclovir , valacyclovir , famcyclovir HAART</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>external genital perianal wart</keyword>
</DOC>